Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10,915,750
-
Number of holders
-
247
-
Total 13F shares, excl. options
-
10,540,926
-
Shares change
-
-143,210
-
Total reported value, excl. options
-
$1,688,047,820
-
Value change
-
-$6,397,458
-
Put/Call ratio
-
76%
-
Number of buys
-
135
-
Number of sells
-
-104
-
Price
-
$160.16
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q2 2018
279 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q2 2018.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 247 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,540,926 shares
of 10,915,750 outstanding shares and own 97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,541,912 shares), RENAISSANCE TECHNOLOGIES LLC (993,066 shares), VANGUARD GROUP INC (983,608 shares), DIMENSIONAL FUND ADVISORS LP (691,408 shares), ACADIAN ASSET MANAGEMENT LLC (453,765 shares), STATE STREET CORP (354,766 shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (230,622 shares), TEACHERS ADVISORS, LLC (192,040 shares), Bank of New York Mellon Corp (174,213 shares), and Man Group plc (170,418 shares).
This table shows the top 247 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.